Aurisco Pharmaceutical Co.,Ltd. (605116.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 10.05B |
| Enterprise Value | 10.29B |
| P/E Ratio | 20.77 |
| PEG Ratio | -2.57 |
| Price/Sales Ratio | 4.51 |
| Price/Book Ratio | 2.87 |
| Enterprise/Revenue | 4.73 |
| Enterprise/EBITDA | 13.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.22 |
| Operating Margin | 0.27 |
| Return On Assets | 0.09 |
| Return On Equity | 0.14 |
| Revenue | 1.7B |
| Revenue/Share | 4.2 |
| Gross Profit | 1.01B |
| EBITDA | 678.98M |
| Net Income | 449.21M |
| Diluted EPS | 1.1 |
| Total Cash | 720.92M |
| Total Cash/Share | 1.78 |
| Total Debt | 1.03B |
| Total Debt/Equity | 0.38 |
| Current Ratio | 4.16 |
| Book Value Per Share | 6.84 |
| 52-Week Change | -18 |
| 52-Week High | 35.58 |
| 52-Week Low | 18.09 |
| Moving Average 50 Days | 19.98 |
| Moving Average 200 Days | 23.48 |
| Average Volume | 3.84M |
| Shares Outstanding | 406.18M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.34 |
| Trailing Annual Dividend Yield | 1.8 |
| Payout Ratio | 0.38 |
| Last Split Factor | N/A |
| Last Split Date | N/A |